October 2026
1. RUIZ P, Deiss L, Buendia L, Merino A, et al
   OPTIMIZATION OF THE RELATIONSHIP WITH PRIMARY CARE TO MAXIMIZE THE DIAGNOSIS OF HEPATITIS B VIRUS INFECTION IN MIGRANT POPULATIONS FROM HIGH-PREVALENCE AREAS: VHBilbao PROJECT.
   Gastroenterol Hepatol. 2026 Oct 9:502894. doi: 10.1016/j.gastrohep.2026.502894.
   

   >> Share

   
   September 2026
2. BUTI M, Aguilera A, Calleja JL, Molero JM, et al
   Corrigendum to "Recommendations for the diagnosis of patients with hepatitis delta virus (HDV) in Spain [Gastroenterologia y Hepatologia 49 (2026) 502768]".
   Gastroenterol Hepatol. 2026 Sep 21:502848. doi: 10.1016/j.gastrohep.2026.502848.
   

   >> Share

   
   August 2026
3. VALLS I, Santos M, Soriano R, Mullol M, et al
   Opportunistic Screening for Hepatitis B and C in Primary Care Using a Reflex Testing System: A Microelimination Model.
   Gastroenterol Hepatol. 2026 Aug 8:502839. doi: 10.1016/j.gastrohep.2026.502839.
   

   >> Share

   
   July 2026
4. ROMERO-VICO J, Duarte B, Vargas-Accarino E, Palom A, et al
   Optimization of a mobile application for the management of hepatitis D based on patient experience: an observational study in a hepatology cohort.
   Gastroenterol Hepatol. 2026 Jul 1:502826. doi: 10.1016/j.gastrohep.2026.502826.
   

   >> Share

   
   June 2026
5. OTERO SR, Lima L, Martin MC, Portero RV, et al
   A decade of progress towards the elimination of hepatitis C: from the National Strategic Plan to Artificial Intelligence.
   Gastroenterol Hepatol. 2026 Jun 11:502821. doi: 10.1016/j.gastrohep.2026.502821.
   

   >> Share

   
   May 2026
6. SANCHEZ-ANTOLIN G, de la Poza G, Hidalgo L, Aguilera MV, et al
   Development and validation of interpretable machine learning models to detect unconfirmed hepatitis C using electronic health records (LiverTAI).
   Gastroenterol Hepatol. 2026 May 5:502774. doi: 10.1016/j.gastrohep.2026.502774.
   

   >> Share

   
   April 2026
7. BUTI M, Aguilera A, Luis Calleja J, Maria Molero J, et al
   Recommendations for the diagnosis of patients with hepatitis delta virus (HDV) in Spain.
   Gastroenterol Hepatol. 2026 Apr 28:502768. doi: 10.1016/j.gastrohep.2026.502768.
   

   >> Share

   
   March 2026
8. MESONERO B, Zanabili J, Granda E, Rodriguez M, et al
   Functional cure of chronic hepatitis B: the friendly face of allogenic hematopoietic stem cell transplantation.
   Gastroenterol Hepatol. 2026 Mar 23:502721. doi: 10.1016/j.gastrohep.2026.502721.
   

   >> Share

   
   
9. LENS S, Garcia F, Mascort J, Casado M, et al
   Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in Spain.
   Gastroenterol Hepatol. 2026 Mar 11:502717. doi: 10.1016/j.gastrohep.2026.502717.
   

   >> Share

   
   December 2025
10. MORENO CO, Romero-Salazar FL, Gomez RM, Jimenez MM, et al
    Effectiveness of Sofosbuvir/Velpatasvir in a Patient with Ultra-Short Bowel Syndrome and Hepatitis C Virus Infection: A Case Report.
    Gastroenterol Hepatol. 2025 Dec 30:502649. doi: 10.1016/j.gastrohep.2025.502649.
    

    >> Share

    
    October 2025
11. PASCUAL-DAPENA A, Pocurull A, Forns X
    Severe Acute Hepatitis E with Unilateral Amyotrophic Neuralgia: A Diagnostic Challenge.
    Gastroenterol Hepatol. 2025 Oct 7:502585. doi: 10.1016/j.gastrohep.2025.502585.
    

    >> Share

    
    June 2025
12. FERNANDEZ AS, Valbuena MB, Arroba CM, Dominguez EG, et al
    Prognostic value of early Lille score in patients with severe alcohol-associated hepatitis.
    Gastroenterol Hepatol. 2025 Jun 20:502517. doi: 10.1016/j.gastrohep.2025.502517.
    

    >> Share

    
    
13. CRESPO J, Albillos A, Buti M
    The Spanish National Strategic Plan for Hepatitis C: A legacy of success.
    Gastroenterol Hepatol. 2025 Jun 13:502457. doi: 10.1016/j.gastrohep.2025.502457.
    

    >> Share

    
    February 2025
14. ROMERO-VICO J, Vargas-Accarino E, Palom A, Fabrellas N, et al
    Utility of mobile applications in the management of hepatitis B: A systematic review.
    Gastroenterol Hepatol. 2025 Feb 19:502395. doi: 10.1016/j.gastrohep.2025.502395.
    

    >> Share

    
    January 2025
15. LUIS CASTRO URDA J, Alvarez M, Cantero H, Ayala V, et al
    The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with undiagnosed HCV infection (Intelligen-C strategy).
    Gastroenterol Hepatol. 2025 Jan 18:502362. doi: 10.1016/j.gastrohep.2025.502362.
    

    >> Share

    
    
16. FORNS X, Rodriguez M, Dominguez-Hernandez R, Cantero H, et al
    Cost analysis of hidden hepatitis D virus infection in Spain.
    Gastroenterol Hepatol. 2025 Jan 8:502337. doi: 10.1016/j.gastrohep.2025.502337.
    

    >> Share

    
    December 2024
17. JIMENEZ-CASTILLO RA, Gonzalez-Martinez CE, Tovar-Bojorquez EM, Cortez-Hernandez CA, et al
    Prognostic value of relative adrenal insufficiency in patients with severe alcohol-associated hepatitis-a prospective clinical study.
    Gastroenterol Hepatol. 2024 Dec 12:502322. doi: 10.1016/j.gastrohep.2024.502322.
    

    >> Share

    
    November 2024
18. LOPEZ DE LA CRUZ J, Gonzalvo MCA, Ortiz de Solorzano Reig M, Aguilar A, et al
    Acute cholestatic hepatitis secondary to idiopathic adult ductopenia.
    Gastroenterol Hepatol. 2024 Nov 14:502289. doi: 10.1016/j.gastrohep.2024.502289.
    

    >> Share

    
    
19. MIRALPEIX A, Ibanez P, Navarro V, Colomera P, et al
    Externalised nurse-led model for hepatitis C virus microelimination and impact of drug use profile.
    Gastroenterol Hepatol. 2024 Nov 13:502288. doi: 10.1016/j.gastrohep.2024.502288.
    

    >> Share

    
    October 2024
20. LUO JX, Chen G, Hu XY, Yu C, et al
    Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis.
    Gastroenterol Hepatol. 2024 Oct 17:502276. doi: 10.1016/j.gastrohep.2024.502276.
    

    >> Share

    
    September 2024
21. BUTI M, Calleja JL, Rodriguez MA, Dominguez-Hernandez R, et al
    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.
    Gastroenterol Hepatol. 2024 Sep 7:502241. doi: 10.1016/j.gastrohep.2024.502241.
    

    >> Share

    
    June 2024
22. BOLIS F, Cazzaniga G, Pagni F, Invernizzi P, et al
    The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants.
    Gastroenterol Hepatol. 2024 Jun 29:502225. doi: 10.1016/j.gastrohep.2024.502225.
    

    >> Share

    
    
23. PARADA VAZQUEZ P, Perez-Cachafeiro S, Castineira Dominguez B, Gonzalez-Perez JM, et al
    Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnes (Spain).
    Gastroenterol Hepatol. 2024 Jun 29:502226. doi: 10.1016/j.gastrohep.2024.502226.
    

    >> Share

    
    
24. RODRIGUEZ-TAJES S, Palom A, Giraldez Gallego A, Moreno A, et al
    Characterizing Hepatitis Delta in Spain and the gaps in its management.
    Gastroenterol Hepatol. 2024 Jun 20:502222. doi: 10.1016/j.gastrohep.2024.502222.
    

    >> Share

    
    May 2024
25. ESTEBAN R, Hernandez RD, Cantero H, Casado MA, et al
    Evaluacion del valor clinico y economico de sofosbuvir/velpatasvir (SOF/VEL) en pacientes con hepatitis C cronica en Espana durante los ultimos 5 anos.
    Gastroenterol Hepatol. 2024 May 7:502199. doi: 10.1016/j.gastrohep.2024.502199.
    

    >> Share

    
    February 2024
26. JORQUERA F, Ledesma F, Ahumada A, Manzano ML, et al
    Clinical profile of Spanish hepatitis C virus-infected treatment-naive patients with compensated cirrhosis in the CREST study.
    Gastroenterol Hepatol. 2024 Feb 12:S0210-5705(24)00037.
    

    >> Share

    
    
27. LIU Y, Chen S, Yu S, Wang J, et al
    LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation.
    Gastroenterol Hepatol. 2024;47:158-169.
    

    >> Share

    
    December 2023
28. CONTHE A, Ahumada A, Gallego Duran R, Marti-Aguado D, et al
    Current dilemmas in hepatitis virus C management. What should we do after achieving sustained virologic response?
    Gastroenterol Hepatol. 2023;46:826-829.
    

    >> Share

    
    
29. RIVEIRO-BARCIELA M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, et al
    mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
    Gastroenterol Hepatol. 2023;46:764-773.
    

    >> Share

    
    
30. ARZALLUS T, Izagirre A, Castiella A, Torrente S, et al
    Drug induced autoimmune hepatitis after turmeric intake.
    Gastroenterol Hepatol. 2023;46:805-806.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share